An accomplished biotechnology executive, Peter DiLaura has nearly 25 years of experience in corporate development, strategy, and business leadership. He joined the company in 2020 from Third Rock Ventures, where he served as an Entrepreneur-in-Residence, focused on building innovative therapeutic companies. Prior to Third Rock, Peter spent five years as the Chief Executive Officer of Second Genome, a therapeutics company developing novel drugs from microbiome science. Earlier in his career, Peter led all corporate development at Ingenuity Systems, a systems biology company. Peter began his career in life sciences as a consultant in the New York office of The Wilkerson Group.
Peter holds a BS in Economics from the Wharton School of the University of Pennsylvania.
At Sonoma Biotherapeutics, Peter is responsible for corporate development, strategic planning, and operations.